Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 55-56 , April 2008

Non-invasive prenatal diagnosis: Implications for antenatal diagnosis and the management of high-risk pregnancies

References 

  1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487
  2. Bianchi DW, Simpson JL, Jackson LG, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn. 2002;22:609–615
  3. Babochkina T, Mergenthaler S, De NG, et al. Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridization analysis, a feature related to a dense compact nucleus with apoptotic character. Haematologica. 2005;90:740–745
  4. Kolialexi A, Vrettou C, Traeger-Synodinos J, et al. Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat Diagn. 2007;27:1228–1232
  5. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13:218–223
  6.  Marteau TM,  Chitty LSSpecial topic issue: fetal sexing: global perspectives on practices, ethics and policy. Prenat Diagn. 2006;26:597–648
  7. Maron JL, Johnson KL, Slonim D, et al. Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest. 2007;117:3007–3019

PII: S1744-165X(07)00151-5

doi: 10.1016/j.siny.2007.12.005

Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 55-56 , April 2008

Article Tools